Study of Abetimus Sodium in Lupus Patients With History of Renal Disease - Trial SLCTR_2008_006
Access comprehensive clinical trial information for SLCTR_2008_006 through Pure Global AI's free database. This Not Applicable trial is sponsored by La Jolla Pharmaceutical Company and is currently Terminated. The study focuses on Systemic Lupus Erythematosus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2008_006
Not Applicable
Terminated
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2008_006
Study of Abetimus Sodium in Lupus Patients With History of Renal Disease
A randomized, double blind, placebo-controlled, three arm, parallel group, multicenter, multinational safety and efficacy trial of 300 mg and 900 mg of abetimus sodium in systemic lupus erythematosus (SLE) patients with a history of renal disease
Study Focus
Interventional
Sponsor & Location
La Jolla Pharmaceutical Company
Argentina, Belarus, Brazil, Czech Republic, Georgia, Germany, HongKong, Hungary, India, Indonesia, N
Timeline & Enrollment
Not Applicable
May 06, 2008
N/A
ICD-10 Classifications
Systemic lupus erythematosus
Systemic lupus erythematosus, unspecified
Lupus erythematosus
Systemic lupus erythematosus with organ or system involvement
Other forms of systemic lupus erythematosus
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2008_006
Non-Device Trial